热门资讯> 正文
Compass Therapeutics提交3亿美元混合证券货架
2024-08-31 05:31
- Compass Therapeutics (NASDAQ:CMPS) filed for $300M mixed securities shelf.
- Filing
More on COMPASS Pathways ADS
- Compass Pathways: Sector-Wide Reality Check Needed Post FDA Lykos MDMA Decision
- Psychedelic Stocks: Focus On Their Cash
- Trials for psychedelic drug candidate for PTSD under scrutiny by FDA - report
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。